Evidence map›Paper›PMID 29772059›Full record

ArticleJournal of neurochemistry2018

The orphan G-protein-coupled receptor 75 signaling is activated by the chemokine CCL5.

Simona Dedoni, Lee A Campbell, Brandon K Harvey, Valeria Avdoshina, Italo Mocchetti

Abstract read
In one paragraph

Article in Journal of neurochemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Gpr75 Deletion in Adipocytes Protects From Diet-Induced Obesity: Changes in Glucose Homeostasis and Inflammatory Responses.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Ciliary localization of GPR75 promotes fat accumulation in mice.The Journal of clinical investigation · 2024
    Article
  12. Central regulation of feeding and body weight by ciliary GPR75.The Journal of clinical investigation · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simona DedoniLaboratory of Preclinical Neurobiology, Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.
Lee A CampbellIntramural Research Program, National Institute on Drug Abuse, Biochemical Research Center, Baltimore, Maryland, USA.
Brandon K HarveyIntramural Research Program, National Institute on Drug Abuse, Biochemical Research Center, Baltimore, Maryland, USA.
Valeria AvdoshinaLaboratory of Preclinical Neurobiology, Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.ORCID 0000-0002-5640-3648
Italo MocchettiLaboratory of Preclinical Neurobiology, Department of Neuroscience, Georgetown University Medical Center, Washington, District of Columbia, USA.ORCID 0000-0002-5010-636X

Funding

Microglia, HIV and drugs of abuseZIADA000586 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2012 to 2025
$6.6M
GPR75: a new CCL5 receptor that mediates neuroprotection against HIVR21NS089446 · NINDS · GEORGETOWN UNIVERSITY · PI MOCCHETTI, ITALO · 2014 to 2015
$428k
NINDS NIH HHS R21 NS089446
6 · The paper itself

Abstract

The chemokine CCL5 prevents neuronal cell death mediated both by amyloid β, as well as the human immunodeficiency virus viral proteins gp120 and Tat. Because CCL5 binds to CCR5, CCR3 and/or CCR1 receptors, it remains unclear which of these receptors plays a role in neuroprotection. Indeed, CCL5 also has neuroprotective activity in cells lacking these receptors. CCL5 may bind to a G-protein-coupled receptor 75 (GPR75), which encodes for a 540 amino-acid orphan receptor of the Gqα family. In this study, we have used SH-SY5Y human neuroblastoma cells to characterize whether CCL5 could activate a Gq signaling through GPR75. Both qPCR and flow cytometry show that these cells express GPR75 but do not express CCR5, CCR3 or CCR1 receptors. SY-SY5Y cells were then used to examine CCL5-mediated signaling. We report that CCL5 promotes a time- and concentration-dependent phosphorylation of protein kinase B (AKT), glycogen synthase kinase 3β, and extracellular signal-regulated kinase (ERK) 1/2. Specific antagonists of CCR5, CCR3, and CCR1 did not prevent CCL5 from increasing phosphorylated AKT or ERK. Moreover, CCL5 promotes a time-dependent internalization of GPR75. Lastly, knocking down GPR75 expression by a CRISPR-Cas9 approach inhibited the ability of CCL5 to activate pERK in SH-SY5Y cells. Therefore, we propose that GPR75 is a novel receptor for CCL5 that could explain some of the pharmacological action of this chemokine. These findings may help in the development of small molecule GPR75 agonists that mimic CCL5. Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/.

Indexed as

AnimalsAntineoplastic AgentsCells, CulturedCerebral CortexChemokine CCL5CRISPR-Associated Protein 9Embryo, MammalianEnzyme InhibitorsGene Expression RegulationHumansMutagenesisNeuroblastomaNeuronsPertussis ToxinProtein TransportRatsAntineoplastic AgentsChemokine CCL5CRISPR-Associated Protein 9Enzyme InhibitorsGPR75 protein, humanPertussis ToxinReceptors, G-Protein-CoupledTretinoinAKTCCR5CRISPR-Cas9CXCR4ERKsignal transduction

Identifiers

PMID29772059
PMCPMC6198807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.